Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus

Lupus. 2011 May;20(6):607-13. doi: 10.1177/0961203310392432. Epub 2011 Mar 21.

Abstract

The underlying mechanisms for the subsets of self-limiting, intermittent or chronic and deforming arthritis in systemic lupus erythematosus (SLE) are not well understood. We performed a cross-sectional analysis of pro-inflammatory cytokines (IL-1β, IL-2, IL-6, IL-8 and TNF-α) and joint status in 47 SLE patients (79% females, age 42 years, disease duration 8.6 years). All cytokines levels were significantly elevated in SLE patients compared with controls, but only IL-2 and IL-8 levels were higher than in patients with rheumatoid arthritis. SLE patients with ongoing synovitis (19%) and joint deformities (11%) had increased erythrocyte sedimentation rate (ESR), IL-6 and anti-dsDNA Ab levels. IL-6 levels correlated with ESR, anti-dsDNA Ab and haemoglobin, but not with C-reactive protein levels. Arthritis constitutes a considerable burden of disease in SLE over time, and joint deformations are associated with longstanding disease and arthritis flare rates. IL-6 is a potential biomarker and therapeutic target in the prevention of joint damage in SLE arthritis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Arthritis, Rheumatoid / blood*
  • Arthritis, Rheumatoid / etiology
  • Biomarkers / blood
  • Blood Sedimentation
  • Case-Control Studies
  • Cross-Sectional Studies
  • Cytokines / blood
  • Female
  • Humans
  • Interleukin-2 / blood
  • Interleukin-6 / blood*
  • Interleukin-8 / blood
  • Joint Deformities, Acquired / epidemiology
  • Joint Deformities, Acquired / etiology*
  • Lupus Erythematosus, Systemic / blood*
  • Lupus Erythematosus, Systemic / complications*
  • Male
  • Middle Aged
  • Registries
  • Synovitis / epidemiology
  • Synovitis / etiology

Substances

  • Biomarkers
  • Cytokines
  • Interleukin-2
  • Interleukin-6
  • Interleukin-8